Øresund Pharma ApS — Credit Rating and Financial Key Figures
CVR number: 39492059
Orient Plads 1, 2150 Nordhavn
info@oresundpharma.com
www.oresundpharma.com
Income statement (kDKK)
2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 | 12 |
| Net sales | |||||
| Gross profit | 4 932.39 | 2 755.00 | 7 275.39 | 17 238.14 | 38 259.55 |
| Employee benefit expenses | -1 529.24 | -2 431.92 | -5 576.03 | -10 054.74 | -15 090.15 |
| Total depreciation | -69.82 | - 344.18 | - 889.10 | -1 065.16 | -1 227.71 |
| EBIT | 3 333.32 | -21.10 | 810.26 | 6 118.25 | 21 941.69 |
| Other financial income | 65.42 | 105.71 | 10.52 | 0.57 | 58.20 |
| Other financial expenses | -51.45 | - 109.39 | - 408.75 | - 595.76 | - 517.01 |
| Pre-tax profit | 3 347.30 | -24.79 | 412.03 | 5 523.07 | 21 482.87 |
| Income taxes | - 778.74 | -61.29 | - 130.78 | -1 220.68 | -4 731.91 |
| Net earnings | 2 568.55 | -86.08 | 281.25 | 4 302.38 | 16 750.97 |
Assets (kDKK)
2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Intangible rights | 300.00 | 748.35 | 2 491.10 | 2 204.68 | 3 320.84 |
| Intangible assets total | 300.00 | 748.35 | 2 491.10 | 2 204.68 | 3 320.84 |
| Machinery and equipment | 929.55 | 1 218.48 | 1 040.71 | 773.29 | 592.15 |
| Tangible assets total | 929.55 | 1 218.48 | 1 040.71 | 773.29 | 592.15 |
| Investments total | 246.50 | ||||
| Non-current loans receivable | 0.71 | 0.71 | 0.71 | 0.71 | 0.71 |
| Non-current other receivables | 251.43 | 256.46 | 270.46 | 363.80 | |
| Long term receivables total | 0.71 | 252.14 | 257.17 | 271.17 | 364.51 |
| Semifinished products | 78.21 | ||||
| Finished products/goods | 1 520.62 | 2 290.21 | 6 919.91 | 7 704.39 | 11 881.06 |
| Advance payments | 744.20 | 1 789.66 | |||
| Inventories total | 2 264.82 | 4 079.88 | 6 919.91 | 7 782.60 | 11 881.06 |
| Current trade debtors | 8 448.24 | 13 574.70 | 10 939.91 | 18 881.84 | 14 836.06 |
| Current amounts owed by group member comp. | 151.75 | 57.26 | 276.55 | 185.46 | 339.29 |
| Prepayments and accrued income | 68.13 | 426.61 | 1 222.63 | 743.25 | 703.29 |
| Current other receivables | 2 031.51 | 2 665.46 | 721.71 | 75.12 | 781.57 |
| Current deferred tax assets | 29.05 | 308.66 | |||
| Short term receivables total | 10 699.64 | 16 724.02 | 13 160.80 | 19 914.73 | 16 968.87 |
| Cash and bank deposits | 3.02 | 2.55 | 43.48 | 4.24 | 9 390.69 |
| Cash and cash equivalents | 3.02 | 2.55 | 43.48 | 4.24 | 9 390.69 |
| Balance sheet total (assets) | 14 444.24 | 23 025.42 | 23 913.17 | 30 950.71 | 42 518.12 |
Equity and liabilities (kDKK)
2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Share capital | 50.00 | 55.60 | 55.60 | 55.60 | 55.60 |
| Retained earnings | 76.86 | 3 139.81 | 3 053.19 | 3 334.45 | 7 636.83 |
| Profit of the financial year | 2 568.55 | -86.08 | 281.25 | 4 302.38 | 16 750.97 |
| Shareholders equity total | 2 695.41 | 3 109.33 | 3 390.04 | 7 692.43 | 24 443.40 |
| Provisions | 30.55 | 50.18 | 24.36 | ||
| Non-current liabilities total | |||||
| Current loans from credit institutions | 1 387.65 | 5 170.62 | 5 743.87 | 6 408.88 | 103.66 |
| Current trade creditors | 8 660.46 | 13 607.50 | 13 154.95 | 14 329.14 | 10 313.44 |
| Short-term deferred tax liabilities | 734.32 | 41.67 | 156.60 | 1 274.10 | 5 011.51 |
| Other non-interest bearing current liabilities | 935.85 | 1 046.13 | 1 443.35 | 1 246.16 | 2 646.11 |
| Current liabilities total | 11 718.27 | 19 865.92 | 20 498.76 | 23 258.28 | 18 074.72 |
| Balance sheet total (liabilities) | 14 444.24 | 23 025.42 | 23 913.17 | 30 950.71 | 42 518.12 |
Try the full version of our system for free
- Professional credit risk reports
- Create your own estimates for any company
- Valuation analysis
- All 400,000+ Danish companies
- See instructions
... and more!
No registration needed.